CPIX
CUMBERLAND PHARMACEUTICALS INC
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · US
$7.32
+1.81%Price chart
Aug 19Aug 24Aug 27Sep 1Sep 4Sep 10Sep 15Sep 18
Key dataSep 18, 2026
Open$7.21
From 52W high−18.39%
Volume23976.00
Market cap$109.68M
P/E (TTM)—
P/S (TTM)3.5x
Div yield20.49%
Key dataSep 18, 2026
Open
$7.21
From 52W high
−18.39%
Volume
23976.00
Market cap
$109.68M
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−19.5x
P/E (TTM)
—
RSI (14)
52.4
MomentumView details →
1D Return
+1.81%
YTD Return
+82.04%
SummaryUpdated Jun 1, 2026
Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX) is a specialty pharmaceutical company founded in 1999 and headquartered in Nashville, Tennessee. The company went public in August 2009 and focuses on acquiring, developing, and commercializing prescription medications primarily for hospital acute care settings. Cumberland has built a portfolio of FDA-approved branded pharmaceutical products while also developing a clinical pipeline of investigational drugs targeting rare diseases and unmet medical needs.
Similar companies
Latest newsMore news →